Today: 20 May 2026
Browse Category

LSE:RR 22 December 2025 - 19 April 2026

Why Rolls-Royce Holdings Is Back in Focus: UK Nuclear Deal, Dividend Date and Fresh Share Momentum

Why Rolls-Royce Holdings Is Back in Focus: UK Nuclear Deal, Dividend Date and Fresh Share Momentum

Rolls-Royce shares jumped 4.8% Friday as UK defence stocks rallied, lifting the FTSE 100. The company goes ex-dividend April 23 and holds its AGM April 30 after announcing a £7–9 billion buyback and a 5 pence final 2025 dividend. Britain signed a contract with Rolls-Royce SMR to begin design work on the first UK small modular reactors. Rolls-Royce also reported German test benches now run on HVO fuel.
19 April 2026
·
Rolls-Royce Holdings plc Expands Poland Defence Bet With PGZ as Europe Rearms

Rolls-Royce Holdings plc Expands Poland Defence Bet With PGZ as Europe Rearms

Rolls-Royce Holdings signed a preliminary agreement with Poland’s PGZ to expand work on propulsion systems for military vehicles and naval vessels. The companies did not disclose financial terms, and the deal falls short of a firm order. The move comes as Poland seeks to access €43.7 billion in EU military loans and European arms imports surge, according to SIPRI data. Rolls-Royce’s mtu engines already power Polish military vehicles, including the new Borsuk.
9 March 2026
·
FTSE 100 just closed at a record — here’s what to watch on the London Stock Exchange next week

FTSE 100 just closed at a record — here’s what to watch on the London Stock Exchange next week

The FTSE 100 closed at a record 10,910.55 on Friday, up 0.6%, marking its third straight all-time high and an eighth consecutive monthly gain. Miners and defensives led the advance, while Barclays dropped 4.2% after the Market Financial Solutions fallout. Rolls-Royce posted a 40% profit jump and announced a major buyback. The Bank of England’s next rate decision is set for March 19.
28 February 2026
·····
FTSE 100 ends flat as Trump tariff reset jars UK stocks; Johnson Matthey sinks

FTSE 100 ends flat as Trump tariff reset jars UK stocks; Johnson Matthey sinks

FTSE 100 closed down 0.02% at 10,684.74 as tariff concerns resurfaced after President Trump announced a new 15% global import levy. FTSE 250 dropped 0.9%. Miners gained on higher gold and oil prices, while software and data stocks fell on AI worries. Johnson Matthey shares plunged over 17% after cutting the sale price of its catalyst unit to Honeywell.
23 February 2026
·····
FTSE 100 closes near record as deal buzz lifts London stocks — here’s what moved UK shares

FTSE 100 closes near record as deal buzz lifts London stocks — here’s what moved UK shares

The FTSE 100 closed up 0.42% at 10,446.35, near record highs, with deal activity and rate-cut bets offsetting AI disruption concerns. NatWest dropped 2.5% after posting £7.7 billion in 2025 pretax profit and announcing a £750 million buyback. Defence shares outperformed, while sterling headed for its biggest weekly loss versus the euro in over two months. Bank of England officials pushed back on rapid rate-cut expectations.
13 February 2026
······
Rolls-Royce shares rebound after a wobble as investors size up the 2026 trade

Rolls-Royce shares rebound after a wobble as investors size up the 2026 trade

Rolls-Royce shares rose 0.8% to 1,264.5 pence in early London trading Thursday, rebounding from a 2% drop the previous day. The company began a £200 million interim share buyback on Jan. 2, set to finish before full-year results on Feb. 26. Analysts cite defence spending and profit targets but warn valuations are high. Rolls-Royce moved from £5.16 billion net debt in 2021 to £1.08 billion net cash by June 2025.
22 January 2026
Rolls-Royce share price steadies near highs as buyback rolls on and Turkey engine hub takes shape

Rolls-Royce share price steadies near highs as buyback rolls on and Turkey engine hub takes shape

Rolls-Royce bought 462,606 shares on Jan. 8 under its £200 million buyback, bringing total repurchases to 2.31 million shares. Shares traded near a 52-week high Friday, ranging from 1,274 to 1,297 pence. The company and Turkish Technic broke ground on a new engine maintenance site at Istanbul Airport, set to open by 2027. Investors await full-year results on Feb. 26.
9 January 2026
··
Rolls-Royce shares hit fresh highs in 2026 rally as valuation debate heats upLondon,

Rolls-Royce shares hit fresh highs in 2026 rally as valuation debate heats upLondon,

Rolls-Royce shares climbed to 1,286 pence Thursday, up 8.5% in the first week of 2026. The stock drew retail and institutional interest as defence-linked shares rallied after U.S. President Trump called for a $1.5 trillion military budget. Rolls-Royce reported £0.9 billion of a planned £1 billion buyback completed and reaffirmed 2025 profit guidance. Full-year results are due Feb. 26.
8 January 2026
·
Rolls-Royce stock rises in London after first buyback trades hit the tape

Rolls-Royce stock rises in London after first buyback trades hit the tape

Rolls-Royce shares rose 2.1% to 1,222.05 pence by 08:30 GMT after the company reported buying 475,882 shares on Jan. 2 under its £200 million buyback programme. The purchases, averaging 1,186.48 pence per share, totaled about £5.6 million. The stock traded near its 52-week high of 1,228.50 pence. Investors await the Feb. 26 full-year results for further updates.
5 January 2026
·
Rolls-Royce Holdings plc Stock (LSE: RR.) on 22 December 2025: Buybacks, Defence Momentum, SMR Tailwinds—and What Analysts Forecast Next

Rolls-Royce Holdings plc Stock (LSE: RR.) on 22 December 2025: Buybacks, Defence Momentum, SMR Tailwinds—and What Analysts Forecast Next

Rolls-Royce Holdings shares traded near 1,166p on Monday, close to 52-week highs after a sharp rally. On 16 December, the company announced a new interim share buyback of up to £200 million, set to run from 2 January to 24 February 2026. The buyback follows a £1 billion programme completed in November. Full-year results are due 26 February.
22 December 2025
··
1 2

Stock Market Today

  • Parabilis Plans IPO to Fund Phase 3 Trial for Tumor Drug Following Regeneron Deal
    May 20, 2026, 5:56 AM EDT. Parabilis Medicines, a Massachusetts biotech, is preparing for an initial public offering (IPO) to finance the phase 3 trial of its tumor drug zolucatetide, targeting rare desmoid tumors. The drug, which inhibits the Wnt/β-catenin pathway implicated in many cancers, recently received FDA fast-track status. Proceeds will also support phase 1 trials for additional cancers. Parabilis secured a $50 million upfront payment and a $75 million equity investment from Regeneron in a deal to explore Parabilis' helicon peptide platform. The firm boasts over $300 million in cash from prior funding rounds. CEO Mathai Mammen aims to grow Parabilis into a fully integrated research, development, manufacturing, and commercialization company, relying on partnerships to finance its ambitions.

Latest articles

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

San Antonio’s New Battery Bet Comes Just as CPS Outages Get Longer

20 May 2026
OCI Energy and CPS Energy have begun building a 120-megawatt battery storage facility in southeastern Bexar County, aiming for commercial operation in 2027. The project follows a rise in average outage duration for CPS Energy customers to 75.38 minutes in 2025. OCI will own the facility, with CPS holding operational control. ING is financing construction, and LG Energy Solution Vertech is supplying batteries.
Co-Diagnostics Jumps; $3 Million Deal Looms

Co-Diagnostics Jumps; $3 Million Deal Looms

20 May 2026
Co-Diagnostics announced a $3 million private placement after its stock surged 43.8% Tuesday, then fell 13.3% in after-hours trading. The company will sell 1.65 million shares or pre-funded warrants, plus warrants for up to 3.29 million more shares, nearly doubling its share count. The move follows its completion of a Bundibugyo virus assay as Ebola spreads in Congo and Uganda. Co-Diagnostics reported $8.2 million in cash at March 31.
Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

Micron Stock Just Dodged the Nasdaq Selloff. A Samsung Strike Could Be Its Next Jolt

20 May 2026
Micron Technology shares rose 2.5% Tuesday to $698.74, lifting its market value near $798 billion as the Nasdaq fell. Analysts cited tight memory supply and strong DRAM and NAND pricing. A planned strike by 48,000 Samsung workers Thursday could disrupt global memory supply, potentially raising prices. Micron recently sampled 256GB DDR5 server modules to partners.
Go toTop